M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 1 375.5 JPY 0.73% Market Closed
Market Cap: 934.1B JPY
Have any thoughts about
M3 Inc?
Write Note

Gross Margin
M3 Inc

57.5%
Current
59%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.5%
=
Gross Profit
142.6B
/
Revenue
247.9B

Gross Margin Across Competitors

Country JP
Market Cap 934B JPY
Gross Margin
58%
Country US
Market Cap 36.5B USD
Gross Margin
74%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 26.4B AUD
Gross Margin
100%
Country US
Market Cap 10.7B USD
Gross Margin
90%
Country US
Market Cap 6.3B USD
Gross Margin
67%
Country US
Market Cap 5.6B USD
Gross Margin
85%
Country SE
Market Cap 53.5B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.2B CNY
Gross Margin
43%
Country US
Market Cap 2.1B USD
Gross Margin
41%
No Stocks Found

M3 Inc
Glance View

Market Cap
934B JPY
Industry
Health Care

M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.

Intrinsic Value
2 281.04 JPY
Undervaluation 40%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.5%
=
Gross Profit
142.6B
/
Revenue
247.9B
What is the Gross Margin of M3 Inc?

Based on M3 Inc's most recent financial statements, the company has Gross Margin of 57.5%.